CN114375199A - 非洲猪瘟疫苗 - Google Patents

非洲猪瘟疫苗 Download PDF

Info

Publication number
CN114375199A
CN114375199A CN202080062696.4A CN202080062696A CN114375199A CN 114375199 A CN114375199 A CN 114375199A CN 202080062696 A CN202080062696 A CN 202080062696A CN 114375199 A CN114375199 A CN 114375199A
Authority
CN
China
Prior art keywords
seq
leu
ile
asn
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080062696.4A
Other languages
English (en)
Chinese (zh)
Inventor
L.迪克森
C.内瑟顿
G.泰勒
D.查普曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pirbright Institute
Original Assignee
Pirbright Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pirbright Institute filed Critical Pirbright Institute
Publication of CN114375199A publication Critical patent/CN114375199A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN202080062696.4A 2019-07-29 2020-07-28 非洲猪瘟疫苗 Pending CN114375199A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1910794.5A GB201910794D0 (en) 2019-07-29 2019-07-29 Vaccine
GB1910794.5 2019-07-29
PCT/GB2020/051808 WO2021019232A1 (en) 2019-07-29 2020-07-28 African swine fever vaccine

Publications (1)

Publication Number Publication Date
CN114375199A true CN114375199A (zh) 2022-04-19

Family

ID=67990353

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080062696.4A Pending CN114375199A (zh) 2019-07-29 2020-07-28 非洲猪瘟疫苗

Country Status (15)

Country Link
US (1) US20220273788A1 (https=)
EP (1) EP4003412A1 (https=)
JP (1) JP2022542174A (https=)
KR (1) KR20220041144A (https=)
CN (1) CN114375199A (https=)
AU (1) AU2020322191A1 (https=)
BR (1) BR112022000865A2 (https=)
CA (1) CA3148586A1 (https=)
CL (1) CL2022000161A1 (https=)
CO (1) CO2022001782A2 (https=)
GB (1) GB201910794D0 (https=)
MX (1) MX2022001028A (https=)
PH (1) PH12022550063A1 (https=)
TW (1) TW202118771A (https=)
WO (1) WO2021019232A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116284261A (zh) * 2023-04-04 2023-06-23 中国人民解放军军事科学院军事医学研究院 一种非洲猪瘟病毒结构蛋白组合物及其制备的疫苗

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113373119A (zh) * 2021-06-02 2021-09-10 江西农业大学 一种表达非洲猪瘟病毒三基因缺失重组伪狂犬病毒毒株、构建方法及其应用
CN116444653B (zh) * 2023-03-09 2024-03-15 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一株阻断性非洲猪瘟病毒单克隆抗体杂交瘤细胞株的制备与应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100086556A1 (en) * 2007-04-17 2010-04-08 Centre De Recerca En Sanitat Animal (Cresa) Use of hemagglutinin of the african swine fever virus as an adjuvant
CN104780937A (zh) * 2012-07-05 2015-07-15 葛兰素史密丝克莱恩生物有限公司 涉及由多核苷酸编码的免疫原性多肽的新型初免-加强方案
WO2017096341A2 (en) * 2015-12-04 2017-06-08 The Texas A&M University System Adenovirus-vectored multivalent vaccine
RU2016115461A (ru) * 2016-04-20 2017-10-25 Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Российской академии сельскохозяйственных наук Рекомбинационная кассета, содержащая гены EP153R и EP364R штамма Congo (КК-262) вируса африканской чумы свиней и рекомбинантный штамм ΔСongoCD2v вируса африканской чумы свиней

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23544A1 (es) * 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
WO2009008888A1 (en) * 2007-07-10 2009-01-15 Matthias Rath African swine virus polypeptides as vaccines and its therapeutic use thereof
EP2202298A1 (en) * 2008-12-23 2010-06-30 Stichting Dienst Landbouwkundig Onderzoek Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
GB201410971D0 (en) * 2014-06-19 2014-08-06 Pirbright Inst The Vaccine
WO2021176235A1 (en) * 2020-03-06 2021-09-10 The Pirbright Institute Vaccine against african swine fever virus infection

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100086556A1 (en) * 2007-04-17 2010-04-08 Centre De Recerca En Sanitat Animal (Cresa) Use of hemagglutinin of the african swine fever virus as an adjuvant
CN104780937A (zh) * 2012-07-05 2015-07-15 葛兰素史密丝克莱恩生物有限公司 涉及由多核苷酸编码的免疫原性多肽的新型初免-加强方案
WO2017096341A2 (en) * 2015-12-04 2017-06-08 The Texas A&M University System Adenovirus-vectored multivalent vaccine
RU2016115461A (ru) * 2016-04-20 2017-10-25 Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Российской академии сельскохозяйственных наук Рекомбинационная кассета, содержащая гены EP153R и EP364R штамма Congo (КК-262) вируса африканской чумы свиней и рекомбинантный штамм ΔСongoCD2v вируса африканской чумы свиней

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
LYNNETTE C. GOATLEY ET AL.: ""A Pool of Eight Virally Vectored African Swine Fever Antigens Protect Pigs against Fatal Disease"", 《VACCINES》, vol. 8, no. 234, pages 1 - 25 *
NATASHA N. GAUDREAULT ET AL.: ""Subunit Vaccine Approaches for African Swine Fever Virus"", 《VACCINES》, vol. 7, no. 56, pages 7 - 8 *
YANEZ, R.J. ET AL.: ""lectin-like protein [African swine fever virus] NP_042751.1"", 《NCBI》, pages 1 - 4 *
YANEZ, R.J. ET AL.: ""pB602L [African swine fever virus] NP_042773.1"", 《NCBI》, pages 1 - 4 *
YANEZ, R.J. ET AL.: ""structural protein p54 [African swine fever virus] NP_042818.1"", 《NCBI》, pages 1 - 4 *
王西西等: ""非洲猪瘟疫苗研究进展"", 《中国动物传染病学报》, vol. 26, no. 2, pages 89 - 94 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116284261A (zh) * 2023-04-04 2023-06-23 中国人民解放军军事科学院军事医学研究院 一种非洲猪瘟病毒结构蛋白组合物及其制备的疫苗
CN116284261B (zh) * 2023-04-04 2024-04-19 中国人民解放军军事科学院军事医学研究院 一种非洲猪瘟病毒结构蛋白组合物及其制备的疫苗

Also Published As

Publication number Publication date
JP2022542174A (ja) 2022-09-29
MX2022001028A (es) 2022-02-23
GB201910794D0 (en) 2019-09-11
AU2020322191A1 (en) 2022-03-03
EP4003412A1 (en) 2022-06-01
PH12022550063A1 (en) 2023-04-12
TW202118771A (zh) 2021-05-16
KR20220041144A (ko) 2022-03-31
BR112022000865A2 (pt) 2022-03-08
CL2022000161A1 (es) 2022-10-21
CO2022001782A2 (es) 2022-06-21
US20220273788A1 (en) 2022-09-01
WO2021019232A1 (en) 2021-02-04
CA3148586A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
CN113666990B (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
CN111088283A (zh) mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗
US10059747B2 (en) Crimean-congo haemorrhagic fever virus antigenic composition
JP5933565B2 (ja) 組み換え改変ワクシニアウイルスアンカラインフルエンザワクチン
AU2022205166B2 (en) Recombinant modified vaccinia virus Ankara (MVA) Foot and mouth disease virus (FMDV) vaccine
WO2011128704A1 (en) Poxvirus expression system
JP2011055840A (ja) 組換えｍｖａおよびその生産方法
CN114375199A (zh) 非洲猪瘟疫苗
US20210113684A1 (en) Vector-based attenuated poxvirus vaccines
JP2023528984A (ja) コロナウイルス病に対する組換え修飾ワクシニアウイルスアンカラ（ｍｖａ）ワクチン
US10894966B2 (en) Virus-based expression vectors and uses thereof
RU2819672C2 (ru) Вакцина против африканской чумы свиней
KR20130058706A (ko) 토끼 출혈병 바이러스의 ｖｐ６０ 주요 캡시드 단백질을 발현하는 파라폭스바이러스
CN117599160A (zh) 狂犬病疫苗免疫原组合物
CN101993498B (zh) 腺病毒载体禽流感重组疫苗
EA044315B1 (ru) Вакцина против вируса ящура (вя) на основе рекомбинантного модифицированного вируса осповакцины анкара (mva)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination